1. Stocks
  2. Piramal Pharma Ltd.
  3. Swot
swot-logo

Piramal Pharma Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Piramal Pharma Ltd. has 16 Strengths, 3 Weaknesses, 5 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Price crossing above SMA20 today, and greater than SMA5

Relative Outperformance versus Industry over 1 Month

Rising Net Cash Flow and Cash from Operating activity

Relative Outperformance versus Industry over 1 Year

Strong Annual EPS Growth

Expensive Performers (DVM)

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Top Gainers

Volume Shockers

Stocks Outperforming their Industry Price Change in the Quarter

PE higher than Industry PE

High PE (PE > 40)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Brokers upgraded recommendation or target price in the past three months

Highest FII stock holdings

FII / FPI or Institutions increasing their shareholding

MFs increased their shareholding last quarter

Mutual Funds Increased Shareholding over the Past Two Months

US FDA Warning Letter

Bullish or Bearish Candlestick Strength - Indices

Expensive Performers (DVM)

Bullish Harami (Bullish Reversal)

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks

Decline in Net Profit with falling Profit Margin (QoQ)